Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dyslipidemia

  Free Subscription


18.03.2019

2 Int J Cardiol
1 J Clin Endocrinol Metab
2 Metabolism
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Int J Cardiol

  1. BREUKER C, Clement F, Mura T, Macioce V, et al
    Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Int J Cardiol. 2018;268:195-199.
    PubMed     Text format     Abstract available

  2. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  3. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Text format     Abstract available


    Metabolism

  4. KANAKIS GA, Nieschlag E
    Klinefelter syndrome: more than hypogonadism.
    Metabolism. 2018;86:135-144.
    PubMed     Text format     Abstract available

  5. ANAGNOSTIS P, Tarlatzis BC, Kauffman RP
    Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.
    Metabolism. 2018;86:33-43.
    PubMed     Text format     Abstract available


    PLoS One

  6. BENITO-VICENTE A, Uribe KB, Siddiqi H, Jebari S, et al
    Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    PLoS One. 2018;13:e0204771.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: